Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer.

By T. Beer, E. Kwon, Charles G. Drake, K. Fizazi, C. Logothetis, G. Gravis, V. Ganju, J. Polikoff, F. Saad, Piotr Humanski and 13 more. Journal of Clinical Oncology, 2017

630 citations recorded by the source corpus.

Subfields: Immunology, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/cac41b1d09f9f3d9ed0b5dae57a698e633cdd847

Citations in the corpus

• Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis (2018, neutral): “>1 concurrent irAE, % 27 (14) 51 (15) 24 (28) .”